retatrutide for diabetes type 2 🩺 in diabetes: TRANSCEND-T2D-1 Phase 3 results → HbA1c ↓2.0% + weight ↓16.8% at 40 weeks. A triple agonist that tackles both glycemia and obesity simultaneously. 📊💊 Ref: Lilly Retatrutide: How it Works, Evidence,

Comparison Table of GLP-1 Treatments in the UK Which GLP-1 Is Best for Weight Loss Results

GLP-1 receptors are present in areas of the brain tied to dopamine signalling and reward processing, which may help explain why some people report reduced interest in alcohol and other substances while taking GLP-1s

A vast number of preclinical and clinical studies have provided evidence for the potential role of GLP-1R agonists in modulating reward-seeking of food, alcohol, cocaine, and amphetamine, offering the possibility of a novel therapeutic alternative for treating addiction [112]

Compound alternatives are not covered by insurance